tirzepatide weight loss panama city FDA Grants a New Indication for Obesity Management Tirzepatide Injections for Medical Weight

GLP-1 receptor agonists are also being increasingly prescribed for weight loss and management

Fatigue often improves within the first few weeks as the body adjusts to GLP-1 therapy

Healthcare providers should assess: Body composition changes (not just weight) to evaluate muscle mass preservation Glycemic control in patients with diabetes, adjusting other medications as needed Thyroid function if symptoms of hypothyroidism develop (fatigue, cold intolerance) Nutritional status through clinical assessment and laboratory testing when indicated Patients experiencing excessive fatigue, cold intolerance, or other symptoms potentially indicating metabolic suppression should be evaluated promptly, though these symptoms more commonly relate to rapid weight loss itself rather than direct drug effects

Notable Characteristic: Reaches the colon intact to serve as a fermentation substrate for beneficial gut bacteria

Meanwhile, other pharma giants have joined the race